34 results
6-K
EX-99.1
MOR
Morphosys AG
20 Mar 24
Current report (foreign)
4:12pm
and to 4.4% in 2025. Inflation is subsiding at a faster rate than anticipated due to positive supply chain developments, including the reduction … events or cybersecurity incidents. Supply Chain Risk MorphoSys does not produce its own active pharmaceutical ingredients but outsources
6-K
EX-99.1
MOR
Morphosys AG
13 Mar 24
Current report (foreign)
4:08pm
and to 4.4% in 2025. Inflation is subsiding at a faster rate than anticipated due to positive supply chain developments, including the reduction … monitoring. The risk of supply chain disruptions is addressed by securing a safety stock. Due to the measures implemented, delays in the supply of products
6-K
EX-99.1
MOR
Morphosys AG
17 Apr 23
Current report (foreign)
8:13am
to address the pandemic on Incyte and its partners’ clinical trials, supply chain, other third-party providers and development and discovery
6-K
EX-99.1
MOR
Morphosys AG
13 Jun 22
Current report (foreign)
4:07pm
; the effects of the COVID-19 pandemic and measures to address the pandemic on Incyte’s clinical trials, supply chain and other third-party providers
6-K
EX-99.1
xe7t5shyleh9fl
23 Mar 22
Current report (foreign)
4:15pm
6-K
EX-99.1
g40ftukjofx
22 Mar 22
Current report (foreign)
4:10pm
6-K
EX-99.1
lvk 7zvxk85v7w
16 Mar 22
2021 Annual Report A nn ua l R ep or t 20 21
4:55pm
6-K
EX-99.1
fw08x0
13 Dec 21
Current report (foreign)
9:56am
6-K
EX-99.1
gwgcbkrxurta0zrd4o
27 Aug 21
MorphoSys and Incyte Announce the European Commission
6:15am
6-K
EX-99.1
shohi
25 Jun 21
Current report (foreign)
10:47am
SC TO-T
EX-99
8uiu5n74jbbzfrdph
16 Jun 21
Third party tender offer statement
4:52pm
6-K
EX-99.1
tkczg bo3v8o2i4zz
4 Jun 21
Presentation will be available on demand as part of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
3:04pm
6-K
EX-99.1
kdebbwa u7flrxyjd0
12 May 21
MorphoSys and Incyte Announce First Patient Dosed in Phase 3
6:19am
6-K
EX-99.1
j0eifl6q
23 Mar 21
Current report (foreign)
3:53pm
6-K
EX-99.1
93z3vkku
22 Mar 21
Current report (foreign)
12:42pm
6-K
EX-99.1
2n9nx9
12 Nov 20
MorphoSys Reports Nine Months and Third Quarter
4:48pm
6-K
EX-99.1
0noh1oblkv c9
12 Nov 20
Third Quarter Interim Statement
11:30am